FDA: codeine, tramadol contraindicated in kids

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • The US Food and Drug Administration (FDA) is adding a new contraindication for all codeine- and tramadol-containing products, precluding their use in children aged <12 y.

Why this matters

  • The action reflects a stronger stance than that of 2013, when boxed warning/contraindications were issued regarding codeine use after tonsillectomy and/or adenoidectomy.

What's changed?

  • Codeine may not be used to treat pain/cough, and tramadol may not be used to treat pain in children aged <12 y.
  • Tramadol may not be used to treat pain after tonsillectomy and/or adenoidectomy in children and teenagers aged <18 y.
  • Both should be avoided in adolescents aged 12-18 y who are obese or have risk factors for breathing problems (eg, obstructive sleep apnea or severe lung disease).
  • The FDA emphasizes that women taking codeine or tramadol should not breast-feed because of risk for excess infant sleepiness, difficulty breast-feeding, and potentially fatal breathing problems.

Why the changes?

  • The FDA has received 64 reports of severe breathing problems (including 24 deaths) related to codeine use in children aged <18 y.
  • 9 cases (including 3 deaths) were reported with use of tramadol in children aged <18 y.
  • Most occurred in children aged <12 y, some after only a single dose.